Grégory Lambert

Grégory Lambert is a notable inventor based in Châtenay-Malabry, France. He has made significant contributions to the field of ophthalmology through his innovative patents. With a total of 2 patents, Lambert's work focuses on improving treatments for eye conditions.

Latest Patents

Lambert's latest patents include an "Oil in water emulsion comprising NSAIDs and quaternary ammonium halides." This oil-in-water emulsion incorporates a non-steroidal anti-inflammatory drug and a quaternary ammonium halide, which is useful for the prevention and treatment of inflammation in the eye. Another significant patent is for "Ophthalmic emulsions containing prostaglandins." These cationic ophthalmic oil-in-water emulsions contain colloid particles with an oily core surrounded by an interfacial film. The emulsions include at least one cationic agent and one non-ionic surfactant, with the oily core containing a prostaglandin for treating ocular hypertension and/or glaucoma. These emulsions enhance the chemical stability of prostaglandins.

Career Highlights

Throughout his career, Grégory Lambert has worked with prominent companies in the pharmaceutical industry, including Novagali Pharma and Santen. His expertise in developing innovative ophthalmic solutions has positioned him as a key figure in the field.

Collaborations

Lambert has collaborated with notable professionals such as Betty Philips and Laura Rabinovich-Guilatt. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Grégory Lambert's contributions to ophthalmic emulsions demonstrate his commitment to innovation in medical treatments. His patents reflect a deep understanding of the complexities involved in eye care, making him a valuable inventor in the field.